Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021
Teva sees API sales surge in Q2
DEF 14A
A jury holds Teva Pharmaceuticals liable in the opioid crisis | WBUR
TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) : Stock Price | US8816242098 | MarketScreener
DEF 14A
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Teva Pharmaceutical Industries Limited 2021 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Definitive Proxy Statement
Teva Pharmaceutical Industries Ltd's (ADR) (TEVA) GmbH and Alder BioPharmaceuticals Form Global License Agreement
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Teva Pharmaceutical Industries (NYSE:TEVA) Has No Shortage Of Debt | Nasdaq
Teva Pharmaceutical Industries Limited 2021 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
Teva Stock Dives As The Sales Downfall Continues For Its Biggest Product | Investor's Business Daily
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
Teva Long-Term Prospects Bright, Despite Headwinds | Nasdaq
DEF 14A
Norman A. Henriquez - Director Finance Shared Service Center - Teva Pharmaceuticals | LinkedIn
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
